Target
Chymotrypsinogen B2
Ligand
BDBM50541586
Substrate
n/a
Meas. Tech.
ChEMBL_1984904 (CHEMBL4618310)
Ki
20±n/a nM
Citation
 Yang, WWang, YLai, AClark, CGCorte, JRFang, TGilligan, PJJeon, YPabbisetty, KBRampulla, RAMathur, AKaspady, MNeithnadka, PRArumugam, ARaju, SRossi, KAMyers, JESheriff, SLou, ZZheng, JJChacko, SABozarth, JMWu, YCrain, EJWong, PCSeiffert, DALuettgen, JMLam, PYSWexler, RREwing, WR Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species. J Med Chem 63:7226-7242 (2020) [PubMed]  Article 
Target
Name:
Chymotrypsinogen B2
Synonyms:
3.4.21.1 | CTRB2 | CTRB2_HUMAN | Chymotrypsin B2 chain A | Chymotrypsin B2 chain B | Chymotrypsin B2 chain C | Chymotrypsinogen B2
Type:
PROTEIN
Mol. Mass.:
27926.36
Organism:
Homo sapiens
Description:
ChEMBL_119704
Residue:
263
Sequence:
MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN
  
Inhibitor
Name:
BDBM50541586
Synonyms:
CHEMBL4638245
Type:
Small organic molecule
Emp. Form.:
C31H29ClF2N4O4
Mol. Mass.:
595.036
SMILES:
COC(=O)Nc1ccc-2c(NC(=O)[C@H](C)CCC[C@H](N3CCC(=CC3=O)c3c(F)ccc(Cl)c3F)c3cc-2ccn3)c1 |r,c:22|
Structure:
Search PDB for entries with ligand similarity: